Future studies should include xenograft or patient-derived tumor models to further investigate the effects of Aurora A and AKT inhibition in combination with radiation in a more clinically relevant setting.Additionally, while our study demonstrates a synergistic anticancer effect, it does not address potential side effects or toxicity concerns associated with dual-targeting strategies. Here, AKT1 is linked to neoplasm.